Curis, Inc. (CRIS)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
Dec 09, 16:00
1.31
-0.02
(-1.50%)
After-Hours: 20:00
Curis Profit Margin (Quarterly): -243.4% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -12.63K% |
| Perspective Therapeutics, Inc. | -12.43K% |
| Protalix Biotherapeutics, Inc. | 13.19% |
| Electromed, Inc. | 12.65% |
| Armata Pharmaceuticals, Inc. | -2.30K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -101.1% |
| Return on Invested Capital | -147.7% |
| Gross Profit Margin (Quarterly) | 98.52% |
| Operating Margin (Quarterly) | -218.0% |
| Return on Net Operating Assets | -244.8% |